Study of levodopa response in Parkinson's disease: Observations on rates of motor progression

被引:11
作者
Ding, Catherine [1 ]
Ganesvaran, Ganga [1 ]
Alty, Jane E. [1 ]
Clissold, Benjamin G. [1 ]
McColl, Craig D. [1 ]
Reardon, Katrina A. [1 ]
Schiff, Mark [1 ]
Srikanth, Velandai [1 ,3 ,4 ]
Kempster, Peter A. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Neurosci, 246 Clayton Rd, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
[3] Monash Univ, Dept Med, Sch Clin Sci, Stroke & Ageing Res Grp,Vasc Brain Aging Div, Melbourne, Vic 3004, Australia
[4] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia
关键词
Parkinson's disease; levodopa; dementia; natural history; SUBSTANTIA-NIGRA; DURATION;
D O I
10.1002/mds.26497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionIt is important to understand how the rate of motor progression in PD relates to dopaminergic treatment. MethodsThe methods for this study comprised prospective defined off state measurements of the levodopa response at 3-year intervals over a mean 13.3-year period in 34 patients enrolled before treatment initiation. ResultsDespite worsening of on and off scores, the magnitude of the l-dopa short-duration response is maintained as the disease progresses. A linear mixed-effects regression analysis of off phase motor scores showed a yearly deterioration of 2.3% of the maximum disability score. Greater motor disability at the commencement of treatment was an independent predictor of faster progression. Demented patients had worse motor function than those without dementia (P = 0.02), and motor deficit appeared to accelerate toward the end of the disease course in patients who had died. ConclusionsThese observations should inform clinical trial design for drugs with possible neuroprotective properties. (c) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码:589 / 592
页数:4
相关论文
共 50 条
  • [31] Rate of Progression of Parkinson’s Disease in Early and Late Prescription of Levodopa
    Rosinskaya A.V.
    Vasenina E.E.
    Khaybullin T.N.
    Levin O.S.
    Neuroscience and Behavioral Physiology, 2019, 49 (7) : 937 - 941
  • [32] Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease
    Sahoo, Lulup Kumar
    Holla, Vikram Venkappayya
    Batra, Dhruv
    Prasad, Shweta
    Bhattacharya, Amitabh
    Kamble, Nitish
    Yadav, Ravi
    Pal, Pramod Kumar
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (12) : 1599 - 1606
  • [33] Levodopa Effect and Motor Function in Late Stage Parkinson's Disease
    Rosqvist, Kristina
    Horne, Malcolm
    Hagell, Peter
    Iwarsson, Susanne
    Nilsson, Maria H.
    Odin, Per
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (01) : 59 - 70
  • [34] Diurnal motor variations to repeated doses of levodopa in Parkinson's disease
    Bonuccelli, U
    Del Dotto, P
    Lucetti, C
    Petrozzi, L
    Bernardini, S
    Gambaccini, G
    Rossi, G
    Piccini, P
    CLINICAL NEUROPHARMACOLOGY, 2000, 23 (01) : 28 - 33
  • [35] Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson’s disease
    Lulup Kumar Sahoo
    Vikram Venkappayya Holla
    Dhruv Batra
    Shweta Prasad
    Amitabh Bhattacharya
    Nitish Kamble
    Ravi Yadav
    Pramod Kumar Pal
    Journal of Neural Transmission, 2020, 127 : 1599 - 1606
  • [36] Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease
    Gao, Lin-Lin
    Zhang, Jia-Rong
    Chan, Piu
    Wu, Tao
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (01) : 76 - 86
  • [37] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188
  • [38] Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review
    Lin, Zhengyu
    Zhang, Chencheng
    Li, Dianyou
    Sun, Bomin
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (02): : 140 - 155
  • [39] Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: A fMRI study
    Peran, P.
    Nemmi, F.
    Meligne, D.
    Cardebat, D.
    Peppe, A.
    Rascol, O.
    Caltagirone, C.
    Demonet, J. F.
    Sabatini, U.
    BRAIN AND LANGUAGE, 2013, 125 (03) : 324 - 329
  • [40] Inferring the long duration response to levodopa in Parkinson's disease
    Nagao, Kanae
    Ding, Catherine
    Ganga, Ganesvaran
    Alty, Jane E.
    Clissold, Benjamin G.
    McColl, Craig D.
    Reardon, Katrina A.
    Schiff, Mark
    Kempster, Peter A.
    PARKINSONISM & RELATED DISORDERS, 2019, 60 : 133 - 137